Pfizer

Conditional market approval for Covaxin, Covishield

January 29, 2022

The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the vaccines will not be available in retail medical stores. What is conditional ..

Month: 

Category: 

Pfizer starts study of mRNA Flu vaccine

September 28, 2021

On September 28, 2021, Pfizer Inc. announced that the first batch of participants have been dosed with the single dose quadrivalent mRNA vaccine in a Phase 1 clinical trial. Highlights Under the phase 1 trial, safety, tolerability, and immunogenicity of ..

Month: 

US announces 500 Million Vaccine doses to Poor Countries

June 11, 2021

United States President Joe Biden has announced to donate 500 million doses of Pfizer COVID-19 vaccine to poorest countries across world to end the pandemic as soon as possible. Key Points This donation is a bold move which showed, US ..

Month: 

Canada approves Mixing & Matching Covid-19 vaccine brands

June 2, 2021

Canada has recommended “mixing and matching” of AstraZeneca, Pfizer and Moderna Covid-19 vaccines. NACI Guidelines National Advisory Committee on Immunization (NACI) had issued guidelines for provinces and territories on mixing and matching second doses of Covid-19 vaccines. It has advised ..

Month: 

WHO clears Chinese Vaccine Sinovac for global use

June 2, 2021

World Health Organisation (WHO) has given approval for global use of covid-19 Vaccine by Sinovac Biotech Ltd. Of China. Highlights WHO recommended its use for people above 18 years. Two-dose will be scheduled for it, with a gap of two ..

Month: 

India to start tests on mixed vaccines

June 1, 2021

According to Dr N K Arora, chairman of Covid-19 working group under National Technical Advisory Group on Immunization (NTAGI), India may soon start testing feasibility of mixing two different doses of Covid vaccines to check whether it helps in boosting ..

Month: 

Pfizer-BioNTech to provide 2 billion Covid-19 vaccine to Poor Nations

May 23, 2021

In a bid to fulfil the international calls for vaccine solidarity, American pharmaceutical company, Pfizer and German company, BioNTech have pledged to provide 2 billion doses of Covid-19 vaccine to poor countries in middle-income and low-income countries in next 18 ..

Month: 

Mixing Covid-19 vaccines increase Vaccine Reactogenicity

May 15, 2021

The researchers in the University of Oxford recently launched “Com-COV Study “. The study was launched to investigate alternate doses of Pfizer-BioNTech vaccine and Oxford-Astra Zeneca vaccine. The researchers have concluded that mixing the administration of these doses in a ..

Month: